首页 正文

Cationic liposome-mediated intra-articular delivery of lorecivivint for osteoarthritis treatment

{{output}}
Osteoarthritis (OA) is the most common joint disease worldwide causing cartilage loss, inflammation and pain. Lorecivivint (LOR) is a new disease-modifying osteoarthritis drug (DMOAD) that targets the Wnt pathway to improve cartilage regeneration and reduce th... ...